Review Articles

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes



Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.


transcatheter aortic valve replacementTAVRsurgical aortic valve replacementSAVRexpandable valves
  • Year: 2017
  • Volume: 13 Issue: 3
  • Page/Article: 126-131
  • DOI: 10.14797/mdcj-13-3-126
  • Published on 1 Jul 2017
  • Peer Reviewed